Daniel E. Singer, MD

Professor of Medicine, Harvard Medical School
Massachusetts General Hospital, Boston, MA
Wellesley, United States

Disclosure information not submitted.

Presentation(s):

• Switching from warfarin to direct oral anticoagulants in older adults with atrial fibrillation: a US nationwide cohort study

  Wednesday, August 28, 2024
  2:00 PM - 2:15 PM CEST

• Comparative effectiveness and safety of extended treatment vs. discontinuation of oral anticoagulants in patients with venous thromboembolism

  Wednesday, August 28, 2024
  2:15 PM - 2:30 PM CEST

• Withholding of oral anticoagulants in patients with dementia and atrial fibrillation by frailty status

  Wednesday, August 28, 2024
  2:30 PM - 2:45 PM CEST

• Effectiveness and Safety of Oral Anticoagulants among patients with Atrial Fibrillation and Advanced Kidney Disease

  Wednesday, August 28, 2024
  2:45 PM - 3:00 PM CEST